Renninger Robert bought ATHA
March 3, 2025 · Form 4 insider transaction
Renninger Robert bought 58,500 shares of Athira Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
58,500
Price
$0.00
Total value
N/A
InsiderRenninger Robert
RoleOfficer
CompanyAthira Pharma, Inc. (ATHA)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2025
Filing dateMarch 4, 2025
Shares owned after58,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.